HMGB1, a novel biomarker of inflammatory demyelinating disease: an interview with Dr. Robert A. Harris.
Rosenberg
Helene F
HF
Laboratory of Allergic Diseases, National Institute of Allergy and Infectious Disease, National Institutes of Health, Bethesda, Maryland, USA. hrosenberg@niaid.nih.gov
D000818:Animals; D015415:Biomarkers / Q000032:analysis; D003711:Demyelinating Diseases / Q000503:physiopathology*; D004195:Disease Models, Animal; D024243:HMGB1 Protein / Q000032:analysis*; D006801:Humans; D007249:Inflammation / Q000175:diagnosis / Q000503:physiopathology*; D051379:Mice
D015415:Biomarkers; D024243:HMGB1 Protein
J Neuroimmunol. 2000 Nov 1;111(1-2):23-33
11063818
EMBO J. 2003 Oct 15;22(20):5551-60
14532127
Arthritis Res Ther. 2008;10(3):209
18598385
Immunity. 2008 Jul 18;29(1):21-32
18631454